Anti-Inflammatory Lifestyle Intervention for Emerging Adult Cancer Survivors
- Conditions
- Survivorship
- Interventions
- Behavioral: Anti-Inflammatory Lifestyle Intervention
- Registration Number
- NCT06442397
- Lead Sponsor
- Virginia Commonwealth University
- Brief Summary
To test the feasibility and acceptability of AILI and associated research procedures among emerging adult cancer survivors (EACS, N=16) age 18-29.
- Detailed Description
This is a single-arm pilot trial designed to assess the feasibility and acceptability of an anti-inflammatory lifestyle intervention (AILI) for emerging adults (EA) adapted for emerging adult cancer survivors (EACS).
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 19
- Age 18-29
- Cancer diagnosis of any type
- Body fat percentage >16.2% for women; >10.6% for men
- Individuals receiving active chemotherapy/radiation or those having completed active chemotherapy/radiation within the past 6 months
- Individuals who are currently pregnant or lactating
- Current involvement in a weight loss program or current use of weight loss medication
- Individuals who report any other uncontrolled medical conditions that may pose a safety issue given the recommendations for the diet and unsupervised physical activity (e.g., uncontrolled hypertension)
- Individuals with rheumatologic and gastrointestinal conditions associated with severe systemic inflammation (e.g., rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease)
- Individuals with medical conditions resulting in known perturbations in the hypothalamic-pituitary-adrenal axis (e.g., endogenous hypercortisolemia [Cushing's syndrome] or adrenal insufficiency)
- Individuals who report a heart condition, chest pain during periods of activity or rest, or loss of consciousness as assessed by the Physical Activity Readiness Questionnaire (PAR-Q)
- Report of lifetime diagnosis of Anorexia Nervosa or Bulimia Nervosa, or any compensatory behaviors (vomiting, laxative abuse) within the previous 3 months
- Hospitalization for depression or other psychiatric disorder within the past 12 months
- Report of lifetime diagnosis of bipolar disorder or psychotic disorder
- Indication of current suicidal intent
- Inability to speak and read English
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Anti-Inflammatory Lifestyle Intervention Anti-Inflammatory Lifestyle Intervention A 16-week program consisting of 12 75-minute virtual group meetings
- Primary Outcome Measures
Name Time Method Test the feasibility of AILI and associated research procedures among EACS age 18-29 4 months The percentage of participants that complete the post intervention questionnaire
Assess the acceptability of AILI and associated research procedures among EACS age 18-29. 4 months Research procedure satisfaction ratings\>/= 3 on a 1-5 Likert scale, where (1) Strongly Disagree; (2) Disagree; (3) Neither Agree nor Disagree; (4) Agree; (5) Strongly Agree.
Test the feasibility of Anti-Inflammatory Lifestyle Intervention (AILI) and associated research procedures among EACS age 18-29. 4 months The percentage of participants that complete the post intervention blood draw
Test the feasibility of Anti-Inflammatory Lifestyle Intervention (AILI) and associated research procedures among emerging adult cancer survivors (EACS) age 18-29 Day 0, At end of recruitment period The percentage of participants that enroll
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Virginia Commonwealth University, School of Medicine
🇺🇸Richmond, Virginia, United States